In recent years, researchers have achieved a breakthrough in preventing cancer cells from evading the immune system using CAR T-cell therapy. Despite the success of CAR T-cell therapies in treating blood- and marrow-based cancers, many challenges currently limit their use in treating other types of cancers.

Read about the technological and clinical hurdles facing CAR T-cell therapies and their application to solid tumors. See how high-throughput assays provide a cost-effective route for the development of CAR-T cells, including topics on:

• Tracking CAR T-cell responses with flow cytometry​​
• Using ddPCR for CAR gene quality control​
• Minimizing CAR T-cell therapy side effects​